The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer

Hematology/oncology Clinics of North America
Adrian G Murphy, Ronan J Kelly

Abstract

The connection between inflammation and malignancy has long been recognized in gastric and esophageal cancers. Given the considerable success of immune checkpoint inhibitors in other tumor types, for example, lung cancer and melanoma, much attention is being paid to furthering their role in gastric and esophageal cancers. The Cancer Genome Atlas has provided further details of the molecular heterogeneity of these tumors, which may help predict responsiveness to immune checkpoint inhibitors. This article discusses the rationale for investigating these agents in gastroesophageal cancer and summarizes the relevant clinical trial data and ongoing studies.

Citations

Jul 17, 2018·Cancer Cell International·Francesca BattaglinHeinz-Josef Lenz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Future Oncology
Kevin SullivanNagashree Seetharamu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Ronan J Kelly, Thomas J Smith
Expert Opinion on Biological Therapy
Nishith SinghJames L Gulley
© 2022 Meta ULC. All rights reserved